Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Eligius F Lyamuya"'
Autor:
Agricola Joachim, Asli Bauer, Sarah Joseph, Christof Geldmacher, Patricia J Munseri, Said Aboud, Marco Missanga, Philipp Mann, Britta Wahren, Guido Ferrari, Victoria R Polonis, Merlin L Robb, Jonathan Weber, Roger Tatoud, Leonard Maboko, Michael Hoelscher, Eligius F Lyamuya, Gunnel Biberfeld, Eric Sandström, Arne Kroidl, Muhammad Bakari, Charlotta Nilsson, Sheena McCormack
Publikováno v:
PLoS ONE, Vol 11, Iss 5, p e0155702 (2016)
BackgroundA vaccine against HIV is widely considered the most effective and sustainable way of reducing new infections. We evaluated the safety and impact of boosting with subtype C CN54rgp140 envelope protein adjuvanted in glucopyranosyl lipid adjuv
Externí odkaz:
https://doaj.org/article/51c62ba07ec84c96b62989aa2999a67b
Autor:
Tosi M. Mwakyandile, Grace A. Shayo, Philip G. Sasi, Ferdinand M. Mugusi, Godfrey Barabona, Takamasa Ueno, Eligius F. Lyamuya
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background The pathogenesis of hypertension (HTN) in people living with HIV/AIDS (PLHIV) is complex and remains not fully understood. Chronic immune activation (IA) is postulated to be one of the culprits. This notion is derived from studies
Externí odkaz:
https://doaj.org/article/6184462c215e4f8dbfd3c0a9b93f9402
Autor:
Agricola Joachim, Charlotta Nilsson, Said Aboud, Muhammad Bakari, Eligius F Lyamuya, Merlin L Robb, Mary A Marovich, Patricia Earl, Bernard Moss, Christina Ochsenbauer, Britta Wahren, Fred Mhalu, Eric Sandström, Gunnel Biberfeld, Guido Ferrari, Victoria R Polonis
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0118486 (2015)
UNLABELLED:Vaccine-induced HIV antibodies were evaluated in serum samples collected from healthy Tanzanian volunteers participating in a phase I/II placebo-controlled double blind trial using multi-clade, multigene HIV-DNA priming and recombinant mod
Externí odkaz:
https://doaj.org/article/30446c161bcb4bdf9632abbd9c8f9720
Autor:
Ephata E Kaaya, Sarah B Macfarlane, Charles A Mkony, Eligius F Lyamuya, Helen Loeser, Phyllis Freeman, Edward K Kirumira, Kisali Pallangyo, Haile T Debas
Publikováno v:
PLoS Medicine, Vol 9, Iss 8, p e1001284 (2012)
Externí odkaz:
https://doaj.org/article/c94ad06432de4cf5b03834f69edcbbe9
Autor:
Tosi M. Mwakyandile, Grace A. Shayo, Philip G. Sasi, Ferdinand M. Mugusi, Godfrey Barabona, Takamasa Ueno, Eligius F. Lyamuya
Publikováno v:
BMC Cardiovascular Disorders, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background Cardiovascular diseases (CVDs) have become an important cause of ill health and death among people living with HIV and/or AIDS (PLHIV) in the antiretroviral therapy (ART) era. There is scarce data on the burden of hypertension (HT
Externí odkaz:
https://doaj.org/article/f3e7c1a1dd484bad87188e59b88a96c1
Autor:
Orgeness J. Mbwambo, Moses Lyatuu, Geofrey Ngocho, Khadija Abdallah, Patricia Godfrey, Bartholomeo N. Ngowi, Alex Mremi, Evangelista Malindisa, Maryam Amour, James Ngocho, Emmanuel Balandya, Gideon Kwesigabo, Rachel Manongi, Benson R. Kidenya, Stephen E. Mshana, Eligius F. Lyamuya, Bruno F. Sunguya, John Bartlett, Blandina Theophil Mmbaga, Alfred K. Mteta
Publikováno v:
Frontiers in Urology, Vol 3 (2023)
BackgroundThe extent of the burden of erectile dysfunction and its associated factors remains unclear. The aim of this study was to investigate the factors associated with ED and its prevalence among MLHIV in northern Tanzania.MethodsA hospital-based
Externí odkaz:
https://doaj.org/article/9f65c0e3fb3b4e7b9f98e5911501ddc2
Autor:
Agricola Joachim, Frank Msafiri, Sayali Onkar, Patricia Munseri, Said Aboud, Eligius F. Lyamuya, Muhammad Bakari, Erik Billings, Merlin L. Robb, Britta Wahren, Fred S. Mhalu, Eric Sandström, Mangala Rao, Charlotta Nilsson, Gunnel Biberfeld
Publikováno v:
Vaccines, Vol 8, Iss 4, p 681 (2020)
We evaluated antibody responses to the human immunodeficiency virus (HIV) envelope variable regions 1 and 2 (V1V2) in 29 vaccinees who had received three HIV-1 DNA immunizations and two HIV-modified vaccinia virus Ankara (MVA) boosts in the phase I/I
Externí odkaz:
https://doaj.org/article/06fc6daf16b849f1aba182d32ba796ee
Publikováno v:
Infection prevention in practice. 4(2)
Multi-drug resistant (MDR) bacteria pose a major global threat to public-health and are of particular concern to hospitalized intensive care unit (ICU) patients. This study aimed at addressing the burden of MDR and the associated factors at admission
Autor:
Agricola Joachim, Mohamed I. M. Ahmed, Georgios Pollakis, Lisa Rogers, Verena S. Hoffmann, Patricia Munseri, Said Aboud, Eligius F. Lyamuya, Muhammad Bakari, Merlin L. Robb, Britta Wahren, Eric Sandstrom, Charlotta Nilsson, Gunnel Biberfeld, Christof Geldmacher, Kathrin Held
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
In the RV144 trial, to date the only HIV-1 vaccine efficacy trial demonstrating a modestly reduced risk of HIV-1 acquisition, antibody responses toward the HIV Envelope protein (Env) variable (V) 2 and V3 regions were shown to be correlated with a re
Autor:
Agricola, Joachim, Sabrina J, Moyo, Lillian, Nkinda, Mtebe, Majigo, Sima, Rugarabamu, Elizabeth G, Mkashabani, Elia J, Mmbaga, Naboth, Mbembati, Said, Aboud, Eligius F, Lyamuya
Publikováno v:
International Journal of Microbiology
Methicillin-resistant Staphylococcus aureus (MRSA) among health care workers (HCWs) increases the risk of spreading the organism in hospital settings. A cross-sectional study was conducted between June and October 2016 among HCWs in tertiary and regi